tiprankstipranks
Trending News
More News >

TMS Co., Ltd. Announces Royalty Payment from CORXEL Dividend

Story Highlights
  • TMS Co., Ltd. will distribute part of a dividend from Corxel Pharmaceuticals to original IP right holders.
  • The payment, up to 69 million yen, will be recorded as non-operating expenses for fiscal year ending February 2025.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
TMS Co., Ltd. Announces Royalty Payment from CORXEL Dividend

Don’t Miss TipRanks’ Half-Year Sale

TMS Co., Ltd. ( (JP:4891) ) has provided an update.

TMS Co., Ltd. announced a resolution to distribute a portion of the dividend received from Corxel Pharmaceuticals Limited to original intellectual property right holders. This payment, amounting to up to 69 million yen, is based on patent assignment contracts and internal rules, and will be recorded as non-operating expenses in the financial statements for the fiscal year ending February 28, 2025. The timing and exact amount of the distribution are still under discussion, but this move reflects TMS’s commitment to honoring its contractual obligations and maintaining transparency with stakeholders.

More about TMS Co., Ltd.

TMS Co., Ltd. is a clinical-stage biopharmaceutical company specializing in the discovery and development of transformative medicines for serious diseases with high unmet medical needs. The company’s pipeline features small molecule compounds known as SMTPs, derived from a fungus, and includes programs targeting acute ischemic stroke, resistant hypertension, acute kidney injury, and spinal cord injury. TMS collaborates with leading academic institutions in Japan to bridge academic discoveries with the global pharmaceutical market.

YTD Price Performance: -4.13%

Average Trading Volume: 1,735,106

Technical Sentiment Consensus Rating: Buy

Current Market Cap: Yen8.43B

For a thorough assessment of 4891 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1